IBM’s Acquisition of ILOG
July 30, 2008
On July 28, 2008, IBM and ILOG, S.A. announced that they have entered into an agreement under which IBM will acquire ILOG, a French company listed on the Eurolist and NASDAQ stock markets and headquartered in Paris, France, and Sunnyvale, California. Cravath is representing IBM on the U.S. aspects of the proposed acquisition. The acquisition will involve concurrent cash tender offers in France and the U.S. at €10 per share, amounting to an aggregate purchase price of approximately US$340 million. The lawyers involved in this acquisition are partners Peter S. Wilson and George A. Stephanakis, European Counsel Mark R. Hageman, associate Vasileios Gkarametsis and summer associates Christopher K. Couvelier and Kevin E. Manz on corporate matters; senior attorney Rolf Zaiss and associate Jarrett R. Hoffman on executive compensation and benefits matters; and associate Robin C. Landis on antitrust matters.
Related Practices & Industries
People
- Photo
-
-
LL.M., 1997, Harvard Law SchoolFulbright Scholar
-
LL.M., 1995, Cambridge University - Faculty of Law
-
LL.B., 1994, University of Athens School of Lawsumma cum laude
- New York
Education
Admitted In
- Photo
-
-
J.D., 1979, Harvard Law Schoolcum laude
-
B.Comm., 1976, McGill Universitywith Great Distinction
Education
Related News & Insights
Deals & Cases
March 31, 2026
Biogen’s $5.6 Billion Acquisition of Apellis
On March 31, 2026, Biogen Inc. and Apellis Pharmaceuticals, Inc. announced that the companies have entered into a definitive agreement under which Biogen has agreed to acquire all outstanding shares of Apellis for $41.00 per share in cash at closing, or approximately $5.6 billion. Apellis stockholders will also receive a nontransferable CVR for each Apellis share held, entitling the holder to receive two payments of $2 per share each, contingent on certain annual global net sales thresholds being met for SYFOVRE®. Cravath is representing Biogen in connection with the transaction.
Deals & Cases
March 09, 2026
Talkspace’s Acquisition by UHS
On March 9, 2026, Universal Health Services, Inc. (“UHS”) announced that it has entered into a definitive agreement to acquire Talkspace, Inc. (“Talkspace”) for $5.25 per share. The enterprise value for the transaction is approximately $835 million. Cravath is representing Talkspace in connection with the transaction.
Deals & Cases
February 18, 2026
Tenax’s Merger with Air
On February 17, 2026, Tenax Aerospace Acquisition, LLC (“Tenax”) and Air Industries Group (“Air”) jointly announced that they have entered into an Agreement and Plan of Merger to combine Tenax’s special mission aviation business with Air’s precision aerospace manufacturing business. At the time of the merger, Air will issue shares of its common stock to holders of Tenax membership units. After the closing, Tenax shareholders are expected to own approximately 95% of Air’s outstanding shares while existing Air shareholders are expected to own approximately 5%, and the combined company expects to remain listed on the NYSE American under the symbol AIRI. Cravath is representing Tenax in connection with the transaction.
Deals & Cases
February 17, 2026
Kennedy Wilson’s Acquisition by Consortium Led by William McMorrow and Fairfax
On February 17, 2026, Kennedy‑Wilson Holdings, Inc. (“Kennedy Wilson”) and Fairfax Financial Holdings Limited (“Fairfax”) jointly announced that Kennedy Wilson has entered into a definitive agreement to be acquired, in an all cash‑transaction, by an entity affiliated with a consortium led by William McMorrow, Chairman and Chief Executive Officer of Kennedy Wilson, and certain other senior executives of Kennedy Wilson (collectively, the “KW Management Group”), together with Fairfax (collectively, the “Consortium”).
